Effects of endotoxemia on the pharmacodynamics and pharmacokinetics of ketamine and xylazine anesthesia in Sprague-Dawley rats

被引:19
作者
Veilleux-Lemieux, Daphnee [1 ,2 ]
Beaudry, Francis [1 ]
Helie, Pierre [3 ]
Vachon, Pascal [1 ]
机构
[1] Univ Montreal, Dept Vet Biomed, Montreal, PQ, Canada
[2] Laval Univ, Dept Vet Sci, Quebec City, PQ, Canada
[3] Univ Montreal, Dept Pathol & Microbiol, Montreal, PQ, Canada
关键词
lipopolysaccharide; ketamine; xylazine; pharmacokinetics; rats;
D O I
10.2147/VMRR.S35666
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Purpose: To evaluate the effects of endotoxemia on the pharmacokinetics and pharmacodynamics of ketamine and xylazine anesthesia in Sprague-Dawley rats. Methods: Sprague-Dawley rats received ketamine (80 mg/kg) and xylazine (5 mg/kg) intramuscularly following the intraperitoneal administration of different lipopolysaccharide concentrations (1, 10, and 100 mu g/kg) to simulate different levels of endotoxemia. Results were compared to control animals receiving saline intraperitoneally. During anesthesia, a toe pinch was performed to evaluate anesthesia duration, and selected physiological parameters (heart and respiratory rates, oxygen saturation, and rectal temperature) were taken. Blood samples were also taken during anesthesia at selected time points for the analysis of plasmatic ketamine and xylazine concentrations by liquid chromatography-mass spectrometry. Blood samples were taken 1 week prior to and 24 hours following anesthesia for blood biochemistry. Results: Anesthesia duration significantly increased for moderate (10 mu g/kg) and high (100 mu g/kg) lipopolysaccharide groups. Liver histopathology showed minor to moderate necrosis in all lipopolysaccharide groups in some animals. The most important physiological change that occurred was a decrease in oxygen saturation, and for blood biochemistry a decrease in serum albumin. Ketamine pharmacokinetics were not affected except for the moderate (10 mu g/kg) lipopolysaccharide group where a decrease in the area under the plasma concentration-time curve from time zero to the last measurable concentration, a decrease in half-life, and an increase in the clearance were observed. For xylazine, the area under the plasma concentration-time curve increased and the clearance decreased in the moderate (10 mu g/kg) and high (100 mu g/kg) lipopolysaccharide groups. Conclusion: During ketamine-xylazine anesthesia, endotoxemia may alter xylazine pharmacokinetics and selected biochemical and physiological parameters, suggesting that anesthetic drug dosages could be modified for a more rapid recovery.
引用
收藏
页码:99 / 109
页数:11
相关论文
共 37 条
[1]  
ALLEN DG, 1986, CAN J VET RES, V50, P23
[2]  
Aydin M, 2011, BRATISL MED J, V112, P227
[3]   In vitro evaluation of differences in phase 1 metabolism of ketamine and other analgesics among humans, horses, and dogs [J].
Capponi, Livia ;
Schmitz, Andrea ;
Thormann, Wolfgang ;
Theurillat, Regula ;
Mevissen, Meike .
AMERICAN JOURNAL OF VETERINARY RESEARCH, 2009, 70 (06) :777-786
[4]   INTERLEUKIN-10 (IL-10) INHIBITS THE RELEASE OF PROINFLAMMATORY CYTOKINES FROM HUMAN POLYMORPHONUCLEAR LEUKOCYTES - EVIDENCE FOR AN AUTOCRINE ROLE OF TUMOR-NECROSIS-FACTOR AND IL-1-BETA IN MEDIATING THE PRODUCTION OF IL-8 TRIGGERED BY LIPOPOLYSACCHARIDE [J].
CASSATELLA, MA ;
MEDA, L ;
BONORA, S ;
CESKA, M ;
CONSTANTIN, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2207-2211
[5]   EFFECT OF RECOMBINANT INTERLEUKIN-10 ON SOME HAEMATOLOGICAL AND BIOCHEMICAL PARAMETERS IN A RAT ENDOTOXAEMIC MODEL [J].
Col, Ramazan ;
Durgun, Zafer .
ACTA VETERINARIA HUNGARICA, 2011, 59 (02) :237-245
[6]   The role of 3' poly(A) tail metabolism in tumor necrosis factor-alpha regulation [J].
Crawford, EK ;
Ensor, JE ;
Kalvakolanu, I ;
Hasday, JD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (34) :21120-21127
[7]   The relationship between body temperature, heart rate and respiratory rate in children [J].
Davies, P. ;
Maconochie, I. .
EMERGENCY MEDICINE JOURNAL, 2009, 26 (09) :641-643
[8]   The effects of inhalation anaesthetics on common clinical pathology parameters in laboratory rats [J].
Deckardt, K. ;
Weber, I. ;
KasperS, U. ;
Hellwig, J. ;
Tennekes, H. ;
van Ravenzwaay, B. .
FOOD AND CHEMICAL TOXICOLOGY, 2007, 45 (09) :1709-1718
[9]  
Dittmar MS, 2004, COMPARATIVE MED, V54, P652
[10]  
FABRE J, 1976, Clinical Pharmacokinetics, V1, P99, DOI 10.2165/00003088-197601020-00002